Notes in 01_Multiple_Sclerosis

To Subscribe, use this Key

Status	Last Update	Fields
Published	02/10/2024	{{c1::Multiple sclerosis (MS)}} is {{c2::a chronic and progressive condition that involves demyelination of the myelinated neurones&nbs…
Published	02/10/2024	Presentation of {{c2::Multiple sclerosis}} {{c1::Symptoms usually progress over more than 24 hours.}} {{c1::Symptoms tend to last days to weeks and th…
Published	02/10/2024	{{c1::Clinically Isolated Syndrome}} is a pattern of Multiple sclerosis that describes the {{c2::first episode of demyelination and neurological signs…
Published	02/10/2024	{{c1::Relapsing-Remitting MS (RRMS)}} is a pattern of Multiple sclerosis that describes the {{c2::most common pattern at initial diagnosis characteris…
Published	02/10/2024	{{c1::Secondary Progressive MS (SPMS)}} is a pattern of Multiple sclerosis that describes the {{c2::presence of relapsing-remitting disease at first, …
Published	02/10/2024	{{c1::Primary Progressive MS (PPMS)}} is a pattern of Multiple sclerosis that describes {{c2::a worsening of disease and neurological symptoms from th…
Published	02/10/2024	Differential Diagnosis of Multiple sclerosis{{c1::Acute Disseminated Encephalomyelitis (ADEM)}}{{c1::Neuromyelitis optica}}{{c1::Sarcoidosis}}
Published	02/10/2024	Diagnosis of {{c2::Multiple Sclerosis}}{{c1::Clinical symptoms}}{{c1::Lumbar puncture shows oligoclonal bands in CSF}}{{c1::MRI shows lesions (e.…
Published	02/10/2024	First-line Disease-Modifying Treatments of Multiple Sclerosis {{c1::Low Efficacy: S/C or I/M Interferons and Glatiramer}} {{c1::Moderate Efficacy: Ora…
Published	02/10/2024	Second-line Disease-Modifying Treatments of Multiple SclerosisHigh Efficacy {{c1::Natalizumab}} {{c1::Ocrelizumab}}
Published	02/10/2024	Relapses of Multiple sclerosis are treated with {{c1::steroids (e.g. methylprednisolone)}}
Status	Last Update	Fields